(Total Views: 775)
Posted On: 04/08/2020 7:07:20 PM
Post# of 155761
“The fact they did this gives me little hope they will approve Leron for use on CV.”
Your reasoning has no basis and honestly, confuses me.
I’m unsure how you went from the CDC’s decision to back off from certain “language” regarding hydroxychloroquine, to assuming this means Leronlimab will not be proved for COVID19.
The CDC does not approve drugs and has ZERO to do with leronlimab’s clinical trial. Like leronlimab, the FDA wants hydroxychloroquime to show efficacy prior to being approved or being touted on any government website as showing any level of efficacy.
If leronlimab shows efficacy in a trial to a level the FDA agrees with, it will be approved. The same goes for hydroxychloroquine. Thus, the CDC’s change today means nothing In terms of chances of approval for either drug.
Your reasoning has no basis and honestly, confuses me.
I’m unsure how you went from the CDC’s decision to back off from certain “language” regarding hydroxychloroquine, to assuming this means Leronlimab will not be proved for COVID19.
The CDC does not approve drugs and has ZERO to do with leronlimab’s clinical trial. Like leronlimab, the FDA wants hydroxychloroquime to show efficacy prior to being approved or being touted on any government website as showing any level of efficacy.
If leronlimab shows efficacy in a trial to a level the FDA agrees with, it will be approved. The same goes for hydroxychloroquine. Thus, the CDC’s change today means nothing In terms of chances of approval for either drug.
(3)
(0)
